Oct 23, 2020 ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of Special Warrants
Oct 21, 2020 ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab
Oct 13, 2020 ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference
Sep 10, 2020 ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Investment Conference
Jul 9, 2020 ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease
Jun 24, 2020 ProMIS Neurosciences announces adjournment and change of location of annual meeting of shareholders
Jun 17, 2020 ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant progress on development of highly accurate antibody test for COVID-19